NASDAQ
Entero Therapeutics, Inc. (ENTO) has a dividends/share growth of -6.42% as of Friday, May 22, 2026. This represents a 142.75% decrease compared to its 12-month average of 15.02%. Dividends per share growth measures the year-over-year percentage change in dividend payments per share.
No price data available for this timeframe.